Clinical Trials List
2023-04-01 - 2026-12-31
Phase I
Not yet recruiting5
Recruiting2
ICD-10C69.40
Malignant neoplasm of unspecified ciliary body
ICD-10C69.41
Malignant neoplasm of right ciliary body
ICD-10C69.42
Malignant neoplasm of left ciliary body
ICD-10Z51.12
Encounter for antineoplastic immunotherapy
ICD-9190.0
Malignant neoplasm of eyeball, except conjunctiva, cornea, retina and choroid
-
Trial Applicant
Chugai Pharma Taiwan Ltd.
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/03/01
Investigators and Locations
Co-Principal Investigator
- Chih-Hung Chen Division of Thoracic Medicine
- Chih-Hsi Kuo Division of Thoracic Medicine
- Cheng-Ta Yang Division of Thoracic Medicine
- Chih-Liang Wang Division of Thoracic Medicine
- Shih-Hong Li Division of Thoracic Medicine
- Ping-Chih Hsu Division of Thoracic Medicine
- Wen-Cheng Chang Division of Hematology & Oncology
- 柯皓文 Division of Thoracic Medicine
- 張境夫 Division of Hematology & Oncology
- Chien-Ying Liu Division of Thoracic Medicine
- 枋岳甫 Division of Thoracic Medicine
The Actual Total Number of Participants Enrolled
0 Not yet recruiting
Co-Principal Investigator
- 徐偉勛 Division of Hematology & Oncology
- Jih-Hsiang Lee Division of Hematology & Oncology
- Wei-Wu Chen Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Not yet recruiting
Co-Principal Investigator
- Heng-Sheng Chao Division of Thoracic Medicine
- 趙恒勝 Division of Thoracic Medicine
- Hsu-ching Huang Division of Thoracic Medicine
- Chia-I Shen Division of Thoracic Medicine
- Yung-Hung Luo Division of Thoracic Medicine
- YEN-HAN TSENG Division of Thoracic Medicine
The Actual Total Number of Participants Enrolled
0 Not yet recruiting
Co-Principal Investigator
- YEN-HSIANG HUANG Division of Thoracic Medicine
- 李柏昕 Division of Thoracic Medicine
- KUO-HSUAN HSU Division of Thoracic Medicine
- JENG-SEN TSENG Division of Thoracic Medicine
The Actual Total Number of Participants Enrolled
0 Not yet recruiting
Co-Principal Investigator
- 王逸熙 Division of Thoracic Medicine
- 鍾聿修 Division of Thoracic Medicine
- 林理涵 Division of Radiology
- 黃詩喻 Division of Hematology & Oncology
- 張晃智 Division of Thoracic Medicine
- 趙東瀛 Division of Thoracic Medicine
- 陳彥豪 Division of Hematology & Oncology
- Chia-Cheng Tseng Division of Thoracic Medicine
- 黃國棟 Division of Thoracic Medicine
- Shau-Hsuan Li Division of Hematology & Oncology
- 林孟志 Division of Thoracic Medicine
- 賴建豪 Division of Thoracic Medicine
- 李易濰 Division of Radiology
- 郭明濬 Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Not yet recruiting
Co-Principal Investigator
- Kai-Ling Lee Division of Thoracic Medicine
- Pai-Chien Chou Division of Thoracic Medicine
- Chi-Li Chung Division of Thoracic Medicine
- Mei-Chuan Chen Division of Thoracic Medicine
- Shih-Hsin Hsiao Division of Thoracic Medicine
- Shang-Fu Hsu Division of Thoracic Medicine
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- Seu-Chun Yang Division of Hematology & Oncology
- Wu-Chou Su Division of Hematology & Oncology
- 蔡政軒 Division of Thoracic Medicine
- Shang-Yin Wu Division of Hematology & Oncology
- Chian-Wei Chen Division of Thoracic Medicine
- Chun-Hui Lee Division of Hematology & Oncology
- Chin-Wei Kuo Division of Thoracic Medicine
The Actual Total Number of Participants Enrolled
0 Recruiting
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
60 participants
-
Global
115-233 participants
